Table 1.
Baseline characteristics of patients supported with the Impella 5.0 device
| Patients characteristics | Total (n = 40) |
|---|---|
| Gender (female/male) | 5/35 |
| Age, years | 57 [48–63] |
| Surgical access femoral/axillary | 30/10 |
| Etiology of cardiogenic shock | |
| Acute ST-elevation myocardial infarction | 17 (43) |
| Dilated cardiomyopathy | 12 (30) |
| Postcardiotomy | 7 (18) |
| Others | 4 (10) |
| Context of MCS | |
| Cardiac arrest before MCS | 9 (23) |
| Transfer from others centers with MCS | 4 (10) |
| Severity at ICU admission | |
| SOFA score | 11 [9–14] |
| SAPS II score | 58 [46–76] |
| Severity and treatment at t0MCS | |
| Mean arterial pressure, mmHg | 60 [50–68] |
| SOFA score | 12 [10–14] |
| Blood lactate, mmol/l | 3.8 [1.7–5.9] |
| IAPB support | 11 (28) |
| Inotrope support | 32 (80) |
| Mechanical ventilation | 29 (73) |
| MCS description | |
| Impella 5.0 alone | 25 (62.5 %) |
| Impella 5.0 added to ongoing ECMO | 15 (37.5 %) |
| Duration of Impella support, days | 7 [5–10] |
| Duration of ECMO, days | 5 [3–8] |
| Total duration of MCS, days | 7 [5–10] |
Data are median [interquartile range] or absolute values (%)
MCS mechanical circulatory support, ICU intensive care unit, SOFA Sepsis-related Organ Failure Assessment, SAPS II Simplified Acute Physiology Score II, t0MCS time of first initiation of MCS, IABP intra-aortic balloon pump, ECMO extracorporeal membrane oxygenation